Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...

Yingli Pharma has obtained US FDA approval for a Phase III trial of linperlisib for R/R peripheral T-cell lymphoma (PTCL).

YCT-529, a hormone-free male birth control pill, has shown high effectiveness in animals and is now in human trials, marking ...

Lenny Santoro was diagnosed with prostate cancer in 2011. Thanks to clinical trials Santoro participated in at the Duke ...

The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will ...

Next Oncology is occupying space in the Texas Medical Center to conduct cancer-fighting clinical trials in Houston.

Toxicity information from phase 3 oncology clinical trials often is incomplete and interpreted in ways that minimize its ...

Durham-based Precision BioSciences Inc. has received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for PBGENE-HBV, an in vivo gene editing program designed ...

Alzheimer's disease, the most common cause of dementia, is currently incurable. The current drugs available have very limited ...

Researchers analyzed pivotal and confirmatory trial characteristics, outcomes, and safety data for 102 cancer drug ...

DelveInsight’s, “Colorectal Cancer Pipeline Insight 2025” report provides comprehensive insights about 195+ companies and ...

Leqembi — sold through a partnership between Eisai Co. and Cambridge-based Biogen — is one of the first medications approved ...